Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Emmanuel Fleck"'
Autor:
Xavier Leleu, Jean-Claude Chomel, André Herbelin, Carine Motard, Stéphanie Ragot, Florence Tartarin, Anne Corby, Guillaume Denis, Jose Torregrosa-Diaz, Deborah Desmier, Thomas Systchenko, Lydia Roy, Jean-Marc Gombert, Emmanuel Fleck, Emilie Cayssials, Pilar Gallego-Hernanz, François Guilhot, Antoine Machet, Natacha Maillard
Publikováno v:
Cancer. 126:3438-3447
Background Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). In clinical practice, tyrosine kinase inhibitor (TKI) dose reductions can be considered a means of preventing adverse effects and improving
Autor:
Emmanuel Fleck, Vincent Delwail, Isabelle Princet, Arthur Bobin, Xavier Leleu, Thomas Systchenko, Elodie Dindinaud, Anthony Levy, Niels Moya, Laly Nsiala, Stéphanie Guidez, Anne Corby, Celine Dieval, Gaelle Olivier, Florence Sabirou, Laura Cailly, Carine Motard, Sabrina Bouyer, Christophe Roul, Guillaume Denis, Cécile Tomowiak, Cécile Gruchet, Céline Debiais, Helene Gardeney
Publikováno v:
Leukemialymphoma. 62(11)
Primary or secondary immune deficiency (ID) is a risk factor, although rare, to develop Waldenström macroglobulinemia (WM). We aimed to better understand the incidence of this occurrence in the real-life and the outcome of either entity. We conducte
Autor:
Jean-Gabriel Fuzibet, Delphine Bauwens, Xavier Leleu, Vincent Javaugue, Florent Plasse, Niels Moya, Helene Gardeney, Sabrina Bouyier, Stéphanie Guidez, Jocelyn Barrier, Paul Franques, Emmanuel Fleck, Florence Sabirou, Valentine Richez, Laurence Legros, Cécile Gruchet, Anthony Bonnin, Guillemette Fouquet, Angela Gil, Isabelle Princet, Jeremie Diolez, Celine Dieval, Anthony Levy, Antoine Brigaud, Frank Bridoux, Hervé Avet-Loiseau, Geraldine Durand, Sylvain Primault, Antoine Machet, Claire Daras, Arthur Bobin, Isabelle Azais
Publikováno v:
American Journal of Hematology. 94:E17-E20
Autor:
Vincent Delwail, Isabelle Princet, Gaelle Olivier, Xavier Leleu, Michele Chabin, Laurence Lacotte-Thierry, Jocelyn Barrier, Cécile Tomowiak, Stéphanie Guidez, Céline Debiais-Delpech, Brigitte Dreyfus, Emmanuel Fleck, Anne Corby, Antoine Machet, Joelle Guilhot, Carine Motard, Katell Le Du
Publikováno v:
British Journal of Haematology
Autor:
Valentine, Richez, Cecile, Gruchet, Stephanie, Guidez, Guillemette, Fouquet, Isabelle, Azais, Geraldine, Durand, Vincent, Javaugue, Antoine, Brigaud, Florent, Plasse, Jéremie, Diolez, Antoine, Machet, Niels, Moya, Helene, Gardeney, Paul, Franques, Arthur, Bobin, Anthony, Levy, Florence, Sabirou, Anthony, Bonnin, Celine, Dieval, Sylvain, Primault, Jocelyn, Barrier, Emmanuel, Fleck, Sabrina, Bouyier, Claire, Daras, Isabelle, Princet, Delphine, Bauwens, Laurence, Legros, Jean-Gabriel, Fuzibet, Angela, Gil, Frank, Bridoux, Hervé, Avet-Loiseau, Xavier, Leleu
Publikováno v:
American journal of hematology. 94(1)
Autor:
Marie Maerevoet, Bertrand Coiffier, Jean Claude Eisenmann, Clémentine Sarkozy, Alain Delmer, Nicolas Mounier, Richard Delarue, Achiel Van Hoof, Michel Fabbro, Emmanuel Fleck, Jean Michel Karsenti
Publikováno v:
Lymphoma. 2014:1-12
In diffuse large B-cell lymphoma (DLBCL), the age-adjusted International Prognostic Index (aaIPI) score is currently used to predict patient outcomes and to choose the best therapeutic treatment. Body mass index (BMI) and gender are occasionally site
Autor:
Isabelle Azais, Guillemette Fouquet, Paul Franques, Sylvain Primault, Angela Gil, Jocelyn Barrier, Cécile Gruchet, Florent Plasse, Antoine Machet, Xavier Leleu, Sabrina Bouyier, Claire Daras, Niels Moya, Helene Gardeney, Stéphanie Guidez, Jeremie Diolez, Franck Bridoux, Arthur Bobin, Jean-Gabriel Fuzibet, Florence Sabirou, Vincent Javaugue, Valentine Richez, Laurence Legros, Geraldine Durand, Anthony Levy, Celine Dieval, Hervé Avet-Loiseau, Isabelle Princet, Antoine Brigaud, Emmanuel Fleck, Delphine Bauwens, Anthony Bonnin
Publikováno v:
Blood. 132:3276-3276
Background. Triplet-based lenalidomide plus dexamethasone combinations have become the new standard of care for early relapse and refractory multiple myeloma (RRMM), including carfilzomib plus lenalidomide/dexamethasone (KRd) based on ASPIRE phase 3
Autor:
Isabelle Princet, Anne Corby, Cécile Tomowiak, Vincent Delwail, Gaelle Olivier, Xavier Leleu, Emmanuel Fleck, Antoine Machet, Joelle Guilhot, Carine Motard, Céline Debiais, Brigitte Dreyfus, Stéphanie Guidez
Publikováno v:
Blood. 132:4231-4231
Background. The Doxorubicin based R-CHOP regimen remains the standard of care for the upfront treatment of DLBCL. The advent of oral idarubicin permitted to develop an all-oral ambulatory oro-CIEP regimen. We hypothesized this regimen would improve t
Autor:
Frank Bridoux, Valentine Richez, Isabelle Princet, Vincent Javaugue, Antoine Brigaud, Delphine Bauwens, Antoine Machet, Hervé Avet-Loiseau, Emmanuel Fleck, Geraldine Durand, Celine Dieval, Niels Moya, Cécile Gruchet, Stéphanie Guidez, Xavier Leleu, Isabelle Azais, Anthony Levy, Arthur Bobin, Guillemette Fouquet, Florence Sabirou
Publikováno v:
Journal of Clinical Oncology. 36:8017-8017
8017Background: Triplet-based lenalidomide plus dexamethasone (Rd) combinations have become the new standard of care for early relapse and refractory multiple myeloma (RRMM), including carfilzomib ...
Autor:
Brigitte Dreyfus, Emmanuel Fleck, Sylvain Choquet, Jean-Christophe Delain, Bernard Grosbois, Omar Benbrahim, Jean Charles Crave, Miguel Carreiro, Bruno Royer, Pierre Clerson, Jean-François Viallard, Vincent Levy
Publikováno v:
Blood. 124:4972-4972
Introduction Patients with hematologic malignancies suffer of frequent, severe, and potentially life-threatening infections. Secondary immune deficiency (SID) could be due to the disease and/or to its treatment (immunosuppressants, immunomodulators,